Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
about
A study of the sympathomimetic action of guanethidine on the isolated anococcygeus muscle of the ratContribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidineCirculatory and respiratory effects of guanethidinADRENERGIC NERVOUS SYSTEM IN SODIUM METABOLISM: EFFECTS OF GUANETHIDINE AND SODIUM-RETAINING STEROIDS IN NORMAL MANTHE EFFECTS OF AUTONOMIC NERVOUS SYSTEM INHIBITION ON THE CIRCULATORY RESPONSE TO MUSCULAR EXERCISE.Pharmacology of N-[2-(2,6-xylyloxy)ethyl]-guanidine sulphate; an adrenergic neurone blocking agent.The release of catechol amines by choline 2,6-XYLYL ether, bretylium and guanethidine.The effect of calcium in removing the blocking action of bretylium and guanethidineThe influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat.The action of guanethidine with particular reference to the sympathetic nervous system.Guanethidine administration in 28 hypertensive patientsThe use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits.Effects of guanethidine on the blood pressure response to splanchnic nerve stimulation in the rat: role of the adrenal medulla.The action of substances which block sympathetic postganglionic nervous transmissionAdrenergic neurone blockade and other acute effects caused by N-benzyl-N'N"-dimethylguanidine and its ortho-chloro derivative.Evidence for a competitive antagonism of guanethidine by dexamphetamine.THE PHARMACOLOGY OF NEW ADRENERGIC NEURONE BLOCKING AGENTS, N-P-CYCLOHEXYLBENZYLTROPINIUM DERIVATIVES.THE EFFECTS OF BRETYLIUM AND GUANETHIDINE ON THE PRESSOR RESPONSES TO NORADRENALINE AND ANGIOTENSIN.Release of noradrenaline from the cat spleen by sodium deprivation.Adrenergic neurone blocking agents: tolerance and hypersensitivity to adrenaline and noradrenaline.The discovery of bretylium and bethanidine.Mechanism of the central hypotensive action of guanethidine.Guanethidine after twenty years: a pharmacologist's perspective.Effect of drugs on the noradrenaline content of brain and peripheral tissues and its significance.Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholineEffect of guanethidine in revealing cholinergic sympathetic fibres.Optical isomers of beta-hydroxyphenethylguanidine: effects on heart noradrenaline and on sympathetic blockadeComparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines.Mechanism of action of guanethidine.Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain.The antihypertensive properties of 1-amino-4-phenyl pyridinium chloride.An investigation of spontaneous potentials recorded from the smooth-muscle cells of the guinea-pig seminal vesicle.
P2860
Q28331604-2FC92480-94C1-4BC2-8BA4-580AE6389DFDQ28363081-23145DE0-03AA-4C03-996C-8D4DFA445421Q33599910-36E25EB0-1243-4DB8-8563-06A65BB12B51Q33953228-2BDBC400-B62D-4773-A359-A144E34B8A38Q34025201-B9B2893F-5159-451F-9BE3-ACB48BCCE195Q34794496-E323D892-B6AE-4047-A7CC-D792EF4171E1Q34794703-07831796-A9BE-458B-B50C-3BC5E547243CQ35011622-A95E7257-3BD3-423B-A518-26327F6479CDQ35039545-30BD9176-E572-49F8-A7E5-A8313E636122Q35227263-33321100-982B-468F-B42D-357EB4C2FC94Q35923127-BB7C35FA-30F2-4A2E-9B15-CACBC92E6F72Q39067231-500D0B97-5F41-4323-BA55-C9B163945976Q41350539-9B1F6BCB-F37C-42B8-9D2C-D76D76F493D0Q41370043-DDEED9C9-B398-4909-9794-0E604DC637C3Q41377027-0E5EE0AE-01DF-43CD-8B0D-D90B42720136Q41377819-65CB2AE4-A7B5-430F-BDD8-4FFF843F37F4Q41386000-A58A6B2E-4867-4F5F-8016-6871A7F7A42DQ41387513-01907316-1A20-4398-83FD-138A40A8D718Q41773875-7E588342-C902-4128-B2B2-E659FA8C9524Q41787394-3CA03B65-BFF4-47F9-90B1-B742A8823ADBQ41815856-CC6AF873-650A-4D45-AE9C-92C2184113F2Q41844413-BFBC597E-7EC0-4847-BF56-D68E2FE81377Q41910124-935E6812-63BF-448B-82A5-5DC3959E5392Q42126184-467EE6CF-B019-4DBF-A1BD-40A1C6562684Q42153497-73607204-6AAA-42E3-8BC3-A67D4FD99C6DQ42180335-279BCC8A-1114-4161-9494-55A1FA1C5EC2Q42246266-23536E86-24B5-48BC-B272-2DAE0514E701Q42400054-868C4161-20BF-4163-9F62-C0B753851D60Q42400084-A27EDF63-FDE1-4392-944E-7CFC111136EAQ42429973-C580EA32-3A8F-4548-8A7F-D840579EDCBEQ42583401-1DE74605-6598-43FC-A2EB-7A8D84811173Q54032863-3745DF7C-ECAE-4AB6-BB88-98837DAE8911
P2860
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
description
1960 nî lūn-bûn
@nan
1960 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1960 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1960年の論文
@ja
1960年論文
@yue
1960年論文
@zh-hant
1960年論文
@zh-hk
1960年論文
@zh-mo
1960年論文
@zh-tw
1960年论文
@wuu
name
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
@ast
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
@en
type
label
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
@ast
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
@en
prefLabel
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
@ast
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).
@en
P2093
P1476
Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864)
@en
P2093
MAXWELL RA
PLUMMER AJ
POVALSKI H
SCHNEIDER F
P407
P577
1960-01-01T00:00:00Z